品牌
经销商厂商性质
上海市所在地
1-十一碳烯821-95-4价格其他中文名称: 1-十一烯
英文名称: 1-Undecene
其他英文名称: 1-Hendecene;1-Undecylene
产品规格: BR,95%
包 装: 25毫升
:821-95-4
C11H22=154.29
级别:BR
含量:≥95.0%
性状:无色液体。能与乙醇混溶,不溶 于水。相对密度 (d2020)0.7787。沸点 192~195℃、84℃(2.40kPa)。折光率(nD)1.4440。闪点 63℃。有刺激性
用途:生化研究。气相色谱分析标准
保存:RT
1-十一碳烯821-95-4价格储存条件: 避光、干燥阴凉处封闭贮存,严禁与有毒、有害物品混放、混运。本品为非危险 产品可按一般化学品运输,轻搬动轻放,防止日晒、雨淋!受热、受潮、受光后易丧失活力,保存期短,因此贮存和运输条件比较苛刻。
产品名称 | 英文名称 | 价格 | |
1-Undecene | 821-95-4 | 电询 |
主要优级纯、分级纯和化学纯3种:
(1)优级纯(GR:Guaranteed reagent),又称一级品或保证试剂,99.8%,这种试剂纯度zui高,杂质含量zui低,适合于重要精密的分析工作和科学研究工作,使用绿色瓶签。
(2)分析纯(AR),又称二级试剂,纯度很高,99.7%,略次于优级纯,适合于重要分析及一般研究工作,使用红色瓶签。
(3)化学纯(CP),又称三级试剂,≥ 99.5%,纯度与分析纯相差较大,适用于工矿、学校一般分析工作。使用蓝色(深蓝色)标签。
(4)实验试剂(LR:Laboratory reagent),又称四级试剂。
公司提供的品质保证,货源充足。严格的质量控制体系,包括:优级纯,分析纯,化学纯,试剂级,基准试剂,实验纯,教学试剂,高纯试剂,色谱纯,光谱纯,电子纯。各种包装规格,并可提供包装定制,咨询订购。
特点:
1,全:公司提供上万种产品,涵盖了生物试剂,elisa试剂盒,标准品,培养基,原装耗材等,基本上各种科研所需产品在我司都能找到。
2,新:产品更新速度较快,基本上每周都有新产品出现。
3,优:产品质量好,*。
4,品牌多:公司代理sigma,amresco,oxoid,wako,R&D,RB,MBL,TCI,GIBIO,等国内外
5.售后:我公司具有优质的技术团队,产品一旦售出,实验过程中遇到困难可提供在线技术咨询。使您使用产品时没有任何的后顾之忧。
2-呋喃丙烯酸 丙基三氯硅烷 2-氟苯甲醛
1-辛基-2,3-二甲基咪唑溴盐 十八烷基三氯硅烷 4-氟-3-甲氧基苯甲醛
2-溴己酸甲酯 正己基三氯硅烷 2-氟-5-甲氧基苯甲醛
1-氟环己基甲醇 三氯-2-氰乙基硅烷 2,4,6-三苯基三嗪
(R)-4-氯-3-羟基丁腈 三溴氟甲烷 1,4-苯并二恶烷
4-氨基-3,5-二氯苯甲酸 1,1,2-三溴乙烷 2,2-双[4-(2-羟基乙氧基)-3,5-二溴苯基]丙烷
(2S,3S)-1,2-环氧-3-(Boc-氨基)-4-苯基丁烷 甲基三乙酰氧基硅烷 1,4,8,11-四氮杂环十四烷
2-(2-氨基噻唑-4-基)乙醛酸乙酯 1,4-噻恶烷 1,4,8,12-四氮杂环十五烷
2-氯-5-三氟甲基吡啶-4-甲酸 三氯化-1,1,2-*基丙基化硅烷 轮环藤宁
亚硝酸异丁酯 正三十四烷 四烯丙氧基乙烷
1-甲基引唑-5-硼酸 四十四烷 十溴二苯乙烷
3-氯苯磺酰氯 2-氨基乙醇硫酸氢酯 3-(2,3-环氧丙氧)丙基*氧基硅烷
4'-叔丁基-4-甲氧基二苯酰甲烷 三(2,3-二溴丙基)异氰脲酸酯 3-氯丙基甲基二甲氧基硅烷
氯化磷酰*钙盐 磷酸三(2-正丁氧乙基)酯 3-氯丙基三乙氧基硅烷
5-溴-2-羟甲基吡啶 *基硅基乙酸 N-氨乙基-3-氨丙基甲基二甲氧基硅烷
8-溴-7-羟基喹啉 2',3',4'-*氧基苯乙酮 丙基三乙氧基硅烷
4-氟-3-甲氧基苯乙酮 三氟乙酸2,2,2-三氟乙酯 N-氨乙基-γ-氨丙基*氧基硅烷
3-甲硫基-1-己醇 三氟乙酰基三氟甲磺酸酐[强效三氟乙酰化试剂] γ-氨丙基甲基二乙氧基硅烷
2-(三氟甲氧基)苯甲酰氯 三氟乙酸异丙酯 双二苯基膦甲烷
2-(二氟甲氧基)苯甲醛 三辛酸甘油酯 1,2-双(二甲基瞵)乙烷
4-氟-3-三氟甲酸 异氰酸2,4,6-三氯苯酯 3-甲基-3-丁烯-2-酮
2,2'-联喹啉 对甲苯磺酸十八烷基酯 1,4-环己烷二羧酸二甲酯
1-二甲基氨基-2-硝基乙烯 顺式-3-己烯醇 2-甲基-2-丁烯酸酯 3-甲基-1,3丁二醇
对二甲苯基醚 乙酸异龙脑酯 4-硝基邻苯二甲酸酐
S-联萘酚磷酸酯 3,3-硫代双丙酸二(十四烷醇)酯 4-氰基苯甲酰氯
4-异丙基苯肼盐酸盐 2,2'-硫代二乙基双[3-(3,5-二叔丁基-4-羟苯基)丙酸酯] N,N-二苄基羟胺
1-氯-2-萘酚 4-吡啶硼酸频哪醇酯 2,4-癸二烯酸乙酯
4-甲氧基-2-(三氟甲基)苯甲醛 N-苄氧羰基-L-天冬氨酸4-苄酯 1,5-双(二苯基膦)戊烷
4,5-二氟-2-溴苯腈 乙酰乙酸甲基丙烯酸乙二醇酯 1,6-双(二苯基膦基)己烷
3,5-二甲氧基溴苄 磷酸三(*基硅基)酯 六甲基二硅烷
2-氟-6-羟基苯腈 1-苯基-2,2,2-三氟乙醇 1-氯-1-苯乙烷
4-硝基水杨酸 (R)-(-)-2,2,2-三氟-1-(9-蒽基)乙醇[以核磁共振旋光纯度测定试剂] 2,2-二氟-1,3-二甲基-咪唑烷
5-溴-2,4-二氟苯磺酰氯 (S)-(+)-2,2,2-三氟-1-(9-蒽基)乙醇 茶螺烷
3,4-二乙氧基苯甲酸 4-乙酰氨基环己醇 异恶唑
2-溴-4-甲酸乙酯吡啶 1H,1H,2H,2H-十三氟-1-正辛醇 聚(已内酯)
5-溴-3-甲基-1H-吲唑 D-(-)-苏-2-氨基-1-(4-硝基苯基)-1,3-丙二醇 4-三氟甲基苯异氰酸
3-氨基-4-甲基苯甲酸甲酯 (1S,2S)-(+)-2-氨基-1-苯基-1,3-丙二醇 对三氟甲基异硫氰酸苯酯
2-甲基* 二氢芳樟醇 N-Boc-L-哌啶-2-羧酸
4-甲酸甲酯苯乙酸甲酯 四乙二醇单十二烷基醚 3-氯-4-甲基苯基异氰酸酯
PPM-18 (25 mg) N-(1,4-dihydro-1,4-dioxo-2-naphthalenyl)-benzamide; NSC 73233; PPM-18
PPM-18 (5 mg) N-(1,4-dihydro-1,4-dioxo-2-naphthalenyl)-benzamide; NSC 73233; PPM-18
1-NM-PP1 (1 mg) 1-(1,1-dimethylethyl)-3-(1-naphthalenylmethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine; PP1 Analog II; 1-NM-PP1
1-NM-PP1 (10 mg) 1-(1,1-dimethylethyl)-3-(1-naphthalenylmethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine; PP1 Analog II; 1-NM-PP1
1-NM-PP1 (25 mg) 1-(1,1-dimethylethyl)-3-(1-naphthalenylmethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine; PP1 Analog II; 1-NM-PP1
1-NM-PP1 (5 mg) 1-(1,1-dimethylethyl)-3-(1-naphthalenylmethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine; PP1 Analog II; 1-NM-PP1
(S)-Glycyl-H-1152 (hydrochloride) (1 mg) 2-ami-[(3S)-hexahydro-3-methyl-4-[(4-methyl-5-isoquinolinyl)sulfonyl]-1H-1,4-diazepin-1-yl]-ethanone, dihydrochloride; Rho Kinase Inhibitor IV; (S)-Glycyl-H-1152 (hydrochloride)
(S)-Glycyl-H-1152 (hydrochloride) (10 mg) 2-ami-[(3S)-hexahydro-3-methyl-4-[(4-methyl-5-isoquinolinyl)sulfonyl]-1H-1,4-diazepin-1-yl]-ethanone, dihydrochloride; Rho Kinase Inhibitor IV; (S)-Glycyl-H-1152 (hydrochloride)
(S)-Glycyl-H-1152 (hydrochloride) (5 mg) 2-ami-[(3S)-hexahydro-3-methyl-4-[(4-methyl-5-isoquinolinyl)sulfonyl]-1H-1,4-diazepin-1-yl]-ethanone, dihydrochloride; Rho Kinase Inhibitor IV; (S)-Glycyl-H-1152 (hydrochloride)
(S)-Glycyl-H-1152 (hydrochloride) (500 ug) 2-ami-[(3S)-hexahydro-3-methyl-4-[(4-methyl-5-isoquinolinyl)sulfonyl]-1H-1,4-diazepin-1-yl]-ethanone, dihydrochloride; Rho Kinase Inhibitor IV; (S)-Glycyl-H-1152 (hydrochloride)
Bisindolylmaleimide VIII (acetate) (1 mg) 3-[1-(3-aminopropyl)-1H-indol-3-yl]-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione, acetate; BIM VIII|Ro 31-7549; Bisindolylmaleimide VIII (acetate)
Bisindolylmaleimide VIII (acetate) (10 mg) 3-[1-(3-aminopropyl)-1H-indol-3-yl]-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione, acetate; BIM VIII|Ro 31-7549; Bisindolylmaleimide VIII (acetate)
Bisindolylmaleimide VIII (acetate) (5 mg) 3-[1-(3-aminopropyl)-1H-indol-3-yl]-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione, acetate; BIM VIII|Ro 31-7549; Bisindolylmaleimide VIII (acetate)
Bisindolylmaleimide IX (mesylate) (1 mg) 3-[3-[2,5-dihydro-4-(1-methyl-1H-indol-3-yl)-2,5-dioxo-1H-pyrrol-3-yl]-1H-indol-1-yl]propyl ester-methanesulfonate, carbamimidothioic acid; BIM IX|Ro 31-822Bisindolylmaleimide IX (mesylate)
Bisindolylmaleimide IX (mesylate) (10 mg) 3-[3-[2,5-dihydro-4-(1-methyl-1H-indol-3-yl)-2,5-dioxo-1H-pyrrol-3-yl]-1H-indol-1-yl]propyl ester-methanesulfonate, carbamimidothioic acid; BIM IX|Ro 31-822Bisindolylmaleimide IX (mesylate)
Bisindolylmaleimide IX (mesylate) (5 mg) 3-[3-[2,5-dihydro-4-(1-methyl-1H-indol-3-yl)-2,5-dioxo-1H-pyrrol-3-yl]-1H-indol-1-yl]propyl ester-methanesulfonate, carbamimidothioic acid; BIM IX|Ro 31-822Bisindolylmaleimide IX (mesylate)
SB 225002 (10 mg) N-(2-bromophenyl)-N’-(2-hydroxy-4-nitrophenyl)-urea; SB 225002
SB 225002 (25 mg) N-(2-bromophenyl)-N’-(2-hydroxy-4-nitrophenyl)-urea; SB 225002
SB 225002 (5 mg) N-(2-bromophenyl)-N’-(2-hydroxy-4-nitrophenyl)-urea; SB 225002
SB 225002 (50 mg) N-(2-bromophenyl)-N’-(2-hydroxy-4-nitrophenyl)-urea; SB 225002
ST638 (1 mg) 2-cyano-3-[3-ethoxy-4-hydroxy-5-[(5-phenylthio)methyl]phenyl]-2-propenamide; ST638
ST638 (10 mg) 2-cyano-3-[3-ethoxy-4-hydroxy-5-[(5-phenylthio)methyl]phenyl]-2-propenamide; ST638
ST638 (25 mg) 2-cyano-3-[3-ethoxy-4-hydroxy-5-[(5-phenylthio)methyl]phenyl]-2-propenamide; ST638
ST638 (5 mg) 2-cyano-3-[3-ethoxy-4-hydroxy-5-[(5-phenylthio)methyl]phenyl]-2-propenamide; ST638
SU 6656 (1 mg) 2,3-dihydro-N,N-dimethyl-2-oxo-3-[(4,5,6,7-tetrahydro-1H-indol-2-yl)methylene]-1H-indole-5-sulfonamide; SU 6656
SU 6656 (10 mg) 2,3-dihydro-N,N-dimethyl-2-oxo-3-[(4,5,6,7-tetrahydro-1H-indol-2-yl)methylene]-1H-indole-5-sulfonamide; SU 6656
SU 6656 (25 mg) 2,3-dihydro-N,N-dimethyl-2-oxo-3-[(4,5,6,7-tetrahydro-1H-indol-2-yl)methylene]-1H-indole-5-sulfonamide; SU 6656
SU 6656 (5 mg) 2,3-dihydro-N,N-dimethyl-2-oxo-3-[(4,5,6,7-tetrahydro-1H-indol-2-yl)methylene]-1H-indole-5-sulfonamide; SU 6656
SQ 22,536 (10 mg) 9-(tetrahydro-2-furanyl)-9H-purin-6-amine; NSC 53339; SQ 22,536
SQ 22,536 (25 mg) 9-(tetrahydro-2-furanyl)-9H-purin-6-amine; NSC 53339; SQ 22,536
SQ 22,536 (5 mg) 9-(tetrahydro-2-furanyl)-9H-purin-6-amine; NSC 53339; SQ 22,536
SQ 22,536 (50 mg) 9-(tetrahydro-2-furanyl)-9H-purin-6-amine; NSC 53339; SQ 22,536
TPEN (10 mg) N,N,N’,N’-tetrakis(2-pyridinylmethyl)-1,2-ethanediamine; TPEDA; TPEN
TPEN (100 mg) N,N,N’,N’-tetrakis(2-pyridinylmethyl)-1,2-ethanediamine; TPEDA; TPEN
TPEN (25 mg) N,N,N’,N’-tetrakis(2-pyridinylmethyl)-1,2-ethanediamine; TPEDA; TPEN
TPEN (50 mg) N,N,N’,N’-tetrakis(2-pyridinylmethyl)-1,2-ethanediamine; TPEDA; TPEN
LY364947 (10 mg) 4-[3-(2-pyridinyl)-1H-pyrazol-4-yl]-quinoline; TGF-β RI Kinase Inhibitor|HTS 466284; LY364947
LY364947 (25 mg) 4-[3-(2-pyridinyl)-1H-pyrazol-4-yl]-quinoline; TGF-β RI Kinase Inhibitor|HTS 466284; LY364947
LY364947 (5 mg) 4-[3-(2-pyridinyl)-1H-pyrazol-4-yl]-quinoline; TGF-β RI Kinase Inhibitor|HTS 466284; LY364947
LY364947 (50 mg) 4-[3-(2-pyridinyl)-1H-pyrazol-4-yl]-quinoline; TGF-β RI Kinase Inhibitor|HTS 466284; LY364947
SB 203580 (hydrochloride) (10 mg) 4-[4-(4-fluorophenyl)-2-[4-(methylsulfinyl)phenyl]-1H-imidazol-5-yl]-pyridine, monohydrochloride; RWJ 64809|PB 20358SB 203580 (hydrochloride)
SB 203580 (hydrochloride) (25 mg) 4-[4-(4-fluorophenyl)-2-[4-(methylsulfinyl)phenyl]-1H-imidazol-5-yl]-pyridine, monohydrochloride; RWJ 64809|PB 20358SB 203580 (hydrochloride)
SB 203580 (hydrochloride) (5 mg) 4-[4-(4-fluorophenyl)-2-[4-(methylsulfinyl)phenyl]-1H-imidazol-5-yl]-pyridine, monohydrochloride; RWJ 64809|PB 20358SB 203580 (hydrochloride)
SB 203580 (hydrochloride) (50 mg) 4-[4-(4-fluorophenyl)-2-[4-(methylsulfinyl)phenyl]-1H-imidazol-5-yl]-pyridine, monohydrochloride; RWJ 64809|PB 20358SB 203580 (hydrochloride)
GYY 4137 (10 mg) (p-methoxyphenyl)morpholino-phosphinodithioic acid; GYY 4137
GYY 4137 (100 mg) (p-methoxyphenyl)morpholino-phosphinodithioic acid; GYY 4137
GYY 4137 (25 mg) (p-methoxyphenyl)morpholino-phosphinodithioic acid; GYY 4137
GYY 4137 (50 mg) (p-methoxyphenyl)morpholino-phosphinodithioic acid; GYY 4137
IBMX (100 mg) 3,9-dihydro-1-methyl-3-(2-methylpropyl)-1H-purine-2,6-dione; Isobutylmethylxanthine|1-Methyl-3-Isobutylxanthine|NSC 16596IBMX
IBMX (250 mg) 3,9-dihydro-1-methyl-3-(2-methylpropyl)-1H-purine-2,6-dione; Isobutylmethylxanthine|1-Methyl-3-Isobutylxanthine|NSC 16596IBMX
IBMX (50 mg) 3,9-dihydro-1-methyl-3-(2-methylpropyl)-1H-purine-2,6-dione; Isobutylmethylxanthine|1-Methyl-3-Isobutylxanthine|NSC 16596IBMX
IBMX (500 mg) 3,9-dihydro-1-methyl-3-(2-methylpropyl)-1H-purine-2,6-dione; Isobutylmethylxanthine|1-Methyl-3-Isobutylxanthine|NSC 16596IBMX
Myristic Acid (1 g) tetradecanoic acid; NSC 5028; Myristic Acid
Myristic Acid (10 g) tetradecanoic acid; NSC 5028; Myristic Acid
Myristic Acid (25 g) tetradecanoic acid; NSC 5028; Myristic Acid
Myristic Acid (5 g) tetradecanoic acid; NSC 5028; Myristic Acid